Prescription drugs represent the fastest rising health care expense in the United States. In the United States, prescription drug rebates are a central piece in the overall economic value proposition for medications manufacturers. Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem where gaps in knowledge, data and technology can create systemic and potentially costly challenges for all stakeholders who provide patients with life-saving and life-changing treatments.
Potential legislative changes may be due to upcoming midterm elections. Please join us to learn how manufacturers can respond quickly to changes in policies, whatever they may be.
In this webinar we will:
- Unpack our current legislative landscape and the implications for drug manufacturers
- Reveal the cost of non-compliance to providers, payors, patients with specific attention to drug manufacturers
- Discuss the use of technology to help eliminate waste and improve efficiency in drug discount management
- Discuss ways that platform solutions can identify and resolve noncompliance issues and detect inconsistencies overlooked by existing methods
Watch the webinar to learn more.